Simpson Thacher represented the underwriters in connection with a registered public offering by GE HealthCare Technologies Inc. (“GEHC”) of $600 million aggregate principal amount of 4.150% Senior Notes due 2028 and $650 million aggregate principal amount of 4.950% Senior Notes due 2035. The offering closed on December 15, 2025.
GEHC intends to use the net proceeds from the offering, together with cash on hand and certain borrowings, to pay all or a portion of the purchase price of the acquisition of Intelerad Medical Systems, to pay associated costs and expenses, and for general corporate purposes, which may include repayment of short-term indebtedness.
To date, the Firm has represented the financing sources in connection with approximately $16 billion of debt and equity financings by GEHC, and related debt-for-debt and debt-for-equity exchanges, since 2022.
GEHC is a leading global medical technology, pharmaceutical diagnostics, and digital solutions innovator, dedicated to providing integrated solutions, services, and data analytics to make hospitals more efficient, clinicians more effective, therapies more precise, and patients healthier and happier.
The Simpson Thacher team for the transaction included Roxane Reardon, David Azarkh, Tina Tang and Marlena Choupo (Capital Markets); Vanessa Burrows and Jacob Madden (Healthcare); Andrew Purcell and Paul Jansch (Tax); Pasco Struhs (Executive Compensation and Employee Benefits); Paige Brinton (IP); and Jennie Getsin (FINRA and Blue Sky).